Vertex Pharmaceuticals
VRTX
VRTX
581 hedge funds and large institutions have $30.4B invested in Vertex Pharmaceuticals in 2017 Q2 according to their latest regulatory filings, with 101 funds opening new positions, 219 increasing their positions, 183 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
581
Holders Change
+60
Holders Change %
+11.52%
% of All Funds
14.51%
Holding in Top 10
8
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.2%
New
101
Increased
219
Reduced
183
Closed
37
Calls
$416M
Puts
$169M
Net Calls
+$247M
Net Calls Change
+$249M
Top Buyers
| 1 |
Jennison Associates
New York
|
+$467M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$207M |
| 3 |
JIM
Jupiter Investment Management
London,
United Kingdom
|
+$144M |
| 4 |
Morgan Stanley
New York
|
+$137M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
+$77.6M |
Top Sellers
| 1 |
Capital World Investors
Los Angeles,
California
|
-$320M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$245M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
-$236M |
| 4 |
JPMorgan Chase & Co
New York
|
-$126M |
| 5 |
Goldman Sachs
New York
|
-$113M |
